-
Federal
Why do antioxidants fail to provide clinical benefit?
U.S. Department of Health & Human Services —
The results of recent randomized trials to test the influence of antioxidants on coronary-event rates and prognosis in patients with coronary-artery disease were... -
Federal
How long should angiotensin-converting enzyme inhibitors be given to patients following myocardial infarction: implications of the HOPE trial
U.S. Department of Health & Human Services —
Long-term treatment with angiotensin-converting enzyme inhibitors reduces post-infarction morbidity and mortality in patients with left ventricular (LV) systolic... -
Federal
Dose response of ACE inhibitors: implications of the SECURE trial
U.S. Department of Health & Human Services —
The choice of the appropriate dosage of ACE inhibitor in clinical practice is an important one. The available evidence suggests that in chronic heart failure as well...